IP Library Assignment 056782/0954
Patent Assignment
Reel/Frame 056782/0954

Security Interest

Recorded: 2021-07-07 Pages: 13
Assignor
CELL MEDICA, INC.
Executed: 2021-07-02
Assignee
OAKTREE FUND ADMINISTRATION, LLC
333 S. GRAND AVENUE, 28TH FL., ATTN: OAKTREE AGENCY, LOS ANGELES, CALIFORNIA, 90071
Covered Properties (22)
Binding Members to Pd-L1
Application: 16/079,210 →
Publication: US US20190055312A1
Modified Cells for Immunotherapy
Application: 16/079,202 →
Publication: US US20190048085A1
Nucleic Acids Encoding Antibodies Against Il-1 Beta
Application: 16/783,339 →
Publication: US US20200362028A1
Nucleic Acid Encoding Antibody to Human Il-1 Beta
Application: 16/118,124 →
Publication: US US20180362642A1
Antibody to Human Il-1 Beta
Application: 16/822,952 →
Publication: US US20200239565A1
Nucleic Acids Encoding Binding Members to Tnf Alpha
Application: 16/258,886 →
Publication: US US20190144532A1
Acceptor Framework for CDR Grafting
Application: 16/879,978 →
Publication: US US20200362059A1
Antibodies Against Il-1 Beta
Patent: 9,914,772 →
Application: 14/740,434 →
Publication: US US20160194392A1
Antibody to Human Il-1 Beta
Patent: 9,404,930 →
Application: 14/072,165 →
Publication: US US20140134183A1
Method of Inhibiting Human Il-1 Beta by Administering an Antibody to Human Il-1 Beta
Application: 15/202,982 →
Publication: US US20170051054A1
Tnf Alpha Antibody or Fragment Thereof and Methods of Use
Application: 15/127,976 →
Publication: US US20170107282A1
Acceptor Framework for Cdr Grafting
Patent: 8,399,624 →
Application: 12/823,488 →
Acceptor Framework for Cdr Grafting
Patent: 9,051,366 →
Application: 13/765,326 →
Publication: US US20130165640A1
Acceptor Framework for Cdr Grafting
Patent: 9,994,645 →
Application: 15/193,432 →
Publication: US US20160347864A1
Acceptor Framework for Cdr Grafting
Patent: 8,399,625 →
Application: 12/823,551 →
Acceptor Framework for Cdr Grafting
Patent: 9,005,924 →
Application: 13/765,302 →
Publication: US US20130165639A1
Acceptor Framework for Cdr Grafting
Patent: 9,409,979 →
Application: 14/644,441 →
Publication: US US20150232543A1
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 8,067,547 →
Application: 11/916,793 →
Publication: US US20090263382A1
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 8,389,693 →
Application: 13/245,420 →
Publication: US US20120064077A1
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 8,691,228 →
Application: 13/708,500 →
Publication: US US20130171143A1
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 9,315,572 →
Application: 14/185,783 →
Publication: US US20140171634A1
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 9,683,034 →
Application: 15/064,067 →
Publication: US US20160185850A1
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 2, 2008
From: BARBERIS, ALCIDE; URECH, DAVID M.; LICHTLEN, PETER; AUF DER MAUR, ADRIAN
To: ESBATECH AG
Reel/Frame 021027/0070 →
Change of Name Dec 11, 2009
From: ESBATECH AG
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT GMBH
Reel/Frame 023639/0314 →
Corrective Assignment to Correct the Legal Status of the Assignee as Llc, Not Gmbh Previously Recorded on Reel 023639 Frame 0314. Assignor(S) Hereby Confirms the Legal Status of the Assignee Is Esbatech, an Alcon Biomedical Research Unit Llc. Jan 4, 2010
From: ESBATECH AG
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
Reel/Frame 023720/0976 →
Assignment of Assignor's Interest Sep 2, 2010
From: ESCHER, DOMINIK
To: ALCON RESEARCH, LTD.
Reel/Frame 024931/0219 →
Assignment of Assignor's Interest Sep 2, 2010
From: ESCHER, DOMINIK
To: A
Reel/Frame 024931/0374 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded on Reel 024931 Frame 0374. Assignor(S) Hereby Confirms the Esbatech, an Alcon Biomedical Research Unit Llc. Sep 25, 2010
From: ESCHER, DOMINIK
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
Reel/Frame 025042/0843 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded on Reel 024931 Frame 0219. Assignor(S) Hereby Confirms the Esbatech, an Alcon Biomedical Research Unit Llc. Sep 25, 2010
From: ESCHER, DOMINIK
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
Reel/Frame 025042/0863 →
Assignment of Assignor's Interest Jan 21, 2014
From: GRABULOVSKI, STEFANIE; KRETZSCHMAR, TITUS; SCHMITT, SIMONE; SHAMSHIEV, ABDIJAPAR
To: DELENEX THERAPEUTICS AG
Reel/Frame 032012/0158 →
Assignment of Assignor's Interest Oct 22, 2015
From: HONEGGER, ANNEMARIE; KRETZSCHMAR, TITUS; SCHMITT, SIMONE; SHAMSHIEV, ABDIJAPAR
To: DELENEX THERAPEUTICS AG
Reel/Frame 036854/0706 →
Change of Name Aug 8, 2016
From: DELENEX THERAPEUTICS AG
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 039629/0573 →
Assignment of Assignor's Interest Oct 20, 2016
From: KRETZSCHMAR, TITUS
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 040078/0694 →
Assignment of Assignor's Interest Oct 20, 2016
From: SHAMSHIEV, ABDIJAPAR
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 040078/0622 →
Assignment of Assignor's Interest Aug 23, 2018
From: ESBATECH, A NOVARTIS COMPANY LLC
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 046677/0476 →
Assignment of Assignor's Interest Jan 21, 2021
From: CELL MEDICA SWITZERLAND AG
To: CELL MEDICA INC.
Reel/Frame 054988/0114 →
Assignment of Assignor's Interest Sep 16, 2021
From: HONEGGER, ANNEMARIE; KRETZSCHMAR, TITUS; SCHMITT, SIMONE; SHAMSHIEV, ABDIJAPAR
To: DELENEX THERAPEUTICS AG
Reel/Frame 057528/0145 →
Assignment of Assignor's Interest Sep 16, 2021
From: CELL MEDICA SWITZERLAND AG
To: CELL MEDICA INC.
Reel/Frame 057528/0455 →
Change of Name Dec 7, 2021
From: DELENEX THERAPEUTICS AG
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 058326/0534 →
Assignment of Assignor's Interest Apr 10, 2022
From: ESBATECH, A NOVARTIS COMPANY LLC
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 059553/0144 →
Assignment of Assignor's Interest Apr 10, 2022
From: ESCHER, DOMINIK
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
Reel/Frame 059553/0097 →
Assignment of Assignor's Interest Jul 18, 2022
From: CELL MEDICA INC.
To: CELL MEDICA, INC.
Reel/Frame 060529/0195 →
Change of Name Jul 18, 2022
From: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
To: ESBATECH, A NOVARTIS COMPANY LLC
Reel/Frame 060529/0545 →
Assignment of Assignor's Interest Jul 18, 2022
From: CELL MEDICA INC.
To: CELL MEDICA, INC.
Reel/Frame 060529/0583 →